A detailed history of American Trust transactions in Abb Vie Inc. stock. As of the latest transaction made, American Trust holds 6,468 shares of ABBV stock, worth $1.11 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
6,468
Previous 7,166 9.74%
Holding current value
$1.11 Million
Previous $1.3 Million 14.95%
% of portfolio
0.1%
Previous 0.12%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Sep 11, 2024

SELL
$154.79 - $180.76 $108,043 - $126,170
-698 Reduced 9.74%
6,468 $1.11 Million
Q1 2024

Jun 11, 2024

BUY
$159.82 - $182.1 $57,055 - $65,009
357 Added 5.24%
7,166 $1.3 Million
Q4 2023

Feb 21, 2024

BUY
$137.6 - $154.97 $45,132 - $50,830
328 Added 5.06%
6,809 $1.06 Million
Q3 2023

Nov 15, 2023

SELL
$133.59 - $154.65 $106,872 - $123,720
-800 Reduced 10.99%
6,481 $966,000
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $28,489 - $35,453
-215 Reduced 2.87%
7,281 $980,000
Q1 2023

May 22, 2023

BUY
$144.61 - $166.54 $18,654 - $21,483
129 Added 1.75%
7,496 $1.19 Million
Q4 2022

Feb 16, 2023

BUY
$138.31 - $165.87 $55,462 - $66,513
401 Added 5.76%
7,367 $1.19 Million
Q3 2022

Dec 02, 2022

SELL
$134.21 - $153.93 $17,447 - $20,010
-130 Reduced 1.83%
6,966 $935,000
Q2 2022

Oct 03, 2022

SELL
$137.62 - $174.96 $62,204 - $79,081
-452 Reduced 5.99%
7,096 $1.09 Million
Q1 2022

Jun 08, 2022

BUY
$131.98 - $163.75 $55,431 - $68,775
420 Added 5.89%
7,548 $1.22 Million
Q4 2021

Mar 17, 2022

BUY
$107.43 - $135.93 $765,761 - $968,909
7,128 New
7,128 $965,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $304B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track American Trust Portfolio

Follow American Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Trust, based on Form 13F filings with the SEC.

News

Stay updated on American Trust with notifications on news.